Cancer deaths plunged 34% across the U.S. from 1991 to 2022. Some 4.5 million lives were extended. Yet that triumph never reached large stretches of the countryside.
Fortune reported Tuesday on research showing the richest counties improved at seven times the rate of the poorest. (https://fortune.com/2026/06/23/cancer-death-rural-urban-wealth-gap-study/) In 458 rural counties cancer mortality actually rose. The patterns echo a broader reversal documented months earlier by the American Cancer Society.
Where once large cities carried the heaviest cancer burden, the opposite now holds. Nonmetropolitan counties with the smallest urban populations post the highest death rates. The crossover happened in the 1990s for men and the early 2000s for women. Since then the rural-urban mortality gap has only widened. American Cancer Society researchers analyzed 27,710,318 cancer deaths spanning 1969 to 2023. (https://pressroom.cancer.org/cancer-in-rural-areas)
Back in 1969-1971 large metropolitan areas recorded the highest overall cancer mortality. Nonmetropolitan areas with fewer than 5,000 urban residents posted the lowest. By 2021-2023 that ranking had flipped. Rural counties now suffer rates that exceed those in big cities by substantial margins. Lung cancer tells the starkest story. Among men the rate in the most rural counties was 26% lower than in large metros in the early 1970s. Fifty years later it ran 55% higher.
Similar reversals appear for colorectal and breast cancer. Prostate cancer rates, once comparable across urbanicity levels, now run 5% to 9% higher outside large metropolitan areas. The data come from National Center for Health Statistics records examined in the Journal of the National Cancer Institute.
Arthur Cosby, a sociology professor at Mississippi State University, reached parallel conclusions studying nearly 3,000 counties from 1981 to 2019. Coastal urban corridors from Boston to Washington and along the Pacific saw the sharpest drops. Manhattan recorded a 47% decline in cancer deaths. Marin County outside San Francisco achieved the same. Many rural counties in Mississippi, Arkansas, West Virginia and Montana saw declines of only 20% to 29%. Hundreds saw increases. “Prior to 1991, rural and urban America generally shared similar rates of cancer mortality,” Cosby wrote in the piece republished by Fortune. “When the national rate started to decline, however, rural and small-town America lagged behind large urban centers.”
Income tells much of the story. When national cancer mortality peaked in 1991, differences between high- and low-income counties were small. By 2019 the top 10% of counties by median family income had posted improvements roughly seven times larger than those in the bottom 10%. The pattern is linear. Greater county wealth tracks directly with faster mortality reductions. Counties lacking financial resources to shoulder the cancer burden recorded the smallest gains.
Explanations cluster around access, behavior and policy. Rural residents face longer travel times to specialists, fewer screening facilities and thinner networks of oncologists. Screening rates run lower. Smoking prevalence stays higher. Tobacco control measures prove weaker. New York City’s aggressive anti-smoking efforts produced a 60% drop in lung cancer deaths in Manhattan. Many rural states and counties adopted fewer taxes, fewer public bans and less cessation support. The result shows up most clearly in lung cancer, which drove much of the national decline.
But smoking is only one piece. Poverty, lower education levels and reduced insurance coverage compound the problem. Late-stage diagnoses become more common. Treatment delays grow longer. Even when innovative therapies reach the market, rural hospitals and clinics often lack the infrastructure or trained staff to deliver them.
A separate ACS study published in MED found cancer survivors in rural or most-deprived areas report poorer health and visit primary or specialty providers less often than urban or affluent survivors. Hyunjung Lee, who led that work, called for team-based survivorship care involving oncologists, primary physicians, nurse practitioners and mental health professionals. “Since each community may have different needs, resources, and collaborative partnerships, different solutions may be necessary,” Lee said. Those solutions could include satellite clinics, expanded telehealth, workforce training and programs that equip non-oncologists to deliver care.
Farhad Islami, senior scientific director for cancer disparity research at the ACS and lead author of the mortality trends study, pointed to social determinants. “Differences in cancer risk factors, and in access to early detection and treatment, are likely major contributors to this shift in the high cancer burden from urban to rural areas,” he said. “Unfortunately, these trends largely reflect growing inequalities in social determinants of health.”
Lisa A. Lacasse, president of the American Cancer Society Cancer Action Network, framed the policy challenge. “All people — no matter where they live — should have a fair and just opportunity to prevent, detect, treat, and survive cancer,” Lacasse said. She urged lawmakers to expand access to comprehensive, affordable care and to require health plans to maintain strong provider networks.
The national statistics still impress. Overall U.S. cancer mortality has fallen steadily for more than three decades. Advances in prevention, screening and treatment produced gains few predicted in the early 1990s. Yet those gains have concentrated along the coasts, in dense metros and in wealthier zip codes. The result is a patchwork map in which proximity to excellence determines survival odds.
Recent analyses reinforce the picture. A 2026 study in CA: A Cancer Journal for Clinicians noted that lung cancer mortality has declined faster in urban than rural areas. Screening uptake remains low overall, with only 18% of eligible people receiving low-dose CT scans in 2022, and rates even lower among younger and Native American populations. Rural areas also show higher incidence and slower mortality drops for several major cancers.
Closing the gap will require more than general progress. Tailored tobacco control for rural communities. Mobile screening units. Investment in rural oncology capacity. Payment reforms that make it viable for specialists to serve low-volume areas. Telehealth expansion that actually reaches patients with poor broadband. None of these steps are simple. Each demands sustained attention from policy makers, health systems and communities.
The data leave little room for doubt. A national success story in cancer control has become, for many rural and low-income Americans, a story of relative abandonment. The tools exist. The knowledge is there. What remains is the harder task of ensuring those tools and that knowledge cross county lines and income thresholds with the same speed they once crossed scientific frontiers. Until that happens the map of cancer mortality will continue to darken in places far from the gleaming medical centers that symbolize American progress.
WebProNews is an iEntry Publication